Financials
- Market Capitalization 5.28 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-135.05
ratio cours/chiffre d'affaires
5.18
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1252 | BLTE Belite Bio Inc - American Depositary Shares | 148.77 USD | +1.42% | -2.32% | +2.61% | +135.73% | 5.85 B USD | ||
| 1276 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 100.01 USD | -1.25% | +1.98% | +21.21% | +421.70% | 5.47 B USD | ||
| 1345 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.69 USD | -0.63% | +0.86% | +93.19% | +202.38% | 4.98 B USD | ||
| 1366 | CRSP CRISPR Therapeutics AG - Common Shares | 51.37 USD | +1.80% | -13.23% | -2.52% | -3.87% | 4.95 B USD |